Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Uchida

Showing results (41-50 of 175) with videos related to

Pageof 18
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|July 25, 2009
Ketogenic diet disrupts the circadian clock and increases hypofibrinolytic risk by inducing expression of plasminogen activator inhibitor-1Katsutaka Oishi, Daisuke Uchida, Naoki Ohkura, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 20, 2004
Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinomaDaisuke Uchida, Nasima-Mila Begum, Yoshifumi Tomizuka, et al.
International Journal of Oncology|June 18, 2004
The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinomaAmmar Almofti, Daisuke Uchida, Nasima Mila Begum, et al.
Molecular Cancer Research : MCR|July 20, 2007
Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinomaDaisuke Uchida, Tomitaro Onoue, Yoshifumi Tomizuka, et al.
Cancers|August 26, 2023
MicroRNA-1289 Functions as a Novel Tumor Suppressor in Oral Squamous Cell CarcinomaKoh-Ichi Nakashiro, Norihiko Tokuzen, Masato Saika, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 14, 2011
[Evaluation of combination chemotherapy with oral S-1 administration followed by docetaxel by superselective intra-arterial infusion for patients with oral squamous cell carcinomas]Hirokazu Nagai, Natsumi Takamaru, Go Ohe, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 17, 2016
Systemic Inflammatory Response Syndrome Is Not an Indicator of Bacteremia in Hemodialysis Patients With Native Accesses: A Multicenter StudyDaisuke Uchida, Sho Sasaki, Hiroo Kawarazaki, et al.
Acta Medica Okayama|June 25, 2020
Serum REIC/Dickkopf-3 Protein Level Predicts Disease-Free Survival in Patients with Hepatocellular CarcinomaAtsushi Oyama, Daisuke Uchida, Hidenori Shiraha, et al.
Oral Oncology|September 19, 2003
Thiazolidinediones inhibit cell growth of human oral squamous cell carcinoma in vitro independent of peroxisome proliferator-activated receptor gammaKoh-ichi Nakashiro, Nasima Mila Begum, Daisuke Uchida, et al.
Oncology Reports|February 13, 2009
Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinomaTohru Ishikawa, Koh-ichi Nakashiro, Sebastian K Klosek, et al.
Pageof 18

Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
Arteriosclerosis, Thrombosis, and Vascular Biology|July 25, 2009
Ketogenic diet disrupts the circadian clock and increases hypofibrinolytic risk by inducing expression of plasminogen activator inhibitor-1Katsutaka Oishi, Daisuke Uchida, Naoki Ohkura, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 20, 2004
Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinomaDaisuke Uchida, Nasima-Mila Begum, Yoshifumi Tomizuka, et al.
International Journal of Oncology|June 18, 2004
The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinomaAmmar Almofti, Daisuke Uchida, Nasima Mila Begum, et al.
Molecular Cancer Research : MCR|July 20, 2007
Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinomaDaisuke Uchida, Tomitaro Onoue, Yoshifumi Tomizuka, et al.
Cancers|August 26, 2023
MicroRNA-1289 Functions as a Novel Tumor Suppressor in Oral Squamous Cell CarcinomaKoh-Ichi Nakashiro, Norihiko Tokuzen, Masato Saika, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 14, 2011
[Evaluation of combination chemotherapy with oral S-1 administration followed by docetaxel by superselective intra-arterial infusion for patients with oral squamous cell carcinomas]Hirokazu Nagai, Natsumi Takamaru, Go Ohe, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 17, 2016
Systemic Inflammatory Response Syndrome Is Not an Indicator of Bacteremia in Hemodialysis Patients With Native Accesses: A Multicenter StudyDaisuke Uchida, Sho Sasaki, Hiroo Kawarazaki, et al.
Acta Medica Okayama|June 25, 2020
Serum REIC/Dickkopf-3 Protein Level Predicts Disease-Free Survival in Patients with Hepatocellular CarcinomaAtsushi Oyama, Daisuke Uchida, Hidenori Shiraha, et al.
Oral Oncology|September 19, 2003
Thiazolidinediones inhibit cell growth of human oral squamous cell carcinoma in vitro independent of peroxisome proliferator-activated receptor gammaKoh-ichi Nakashiro, Nasima Mila Begum, Daisuke Uchida, et al.
Oncology Reports|February 13, 2009
Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinomaTohru Ishikawa, Koh-ichi Nakashiro, Sebastian K Klosek, et al.
Pageof 18